Burkholderia cepacia (Palleroni and Holmes) Yabuuchi et al. (ATCC® 700070)

Strain Designations: K61-3  /  Type Strain: no  /  Biosafety Level: 2

Permits And Restrictions

View Permits

Strain Designations K61-3
Patient with cystic fibrosis, Canada
Type Strain no
Biosafety Level 2
Product Format freeze-dried
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Preceptrol® no
Type Strain no
Antibiotic Resistance
Chloramphenicol-, ciprofloxacin-, and trimethoprim-resistant
Medium ATCC® Medium 3: Nutrient agar or nutrient broth
Growth Conditions
Temperature: 30°C
Atmosphere: Aerobic
Name of Depositor JL Burns
Special Collection NCRR Contract
Chain of Custody
ATCC <-- JL Burns <-- D Woods <-- C Prober
Patient with cystic fibrosis, Canada

Burns JL, et al. Chloramphenicol resistance in Pseudomonas cepacia because of decreased permeability. Antimicrob. Agents Chemother. 33: 136-141, 1989. PubMed: 2719457

Burns JL, et al. Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance. Antimicrob. Agents Chemother. 40: 307-313, 1996. PubMed: 8834871

Cross References

Nucleotide (GenBank) : U38944 cDNA for outer membrane protein, opcM

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation